{
    "code": "02020903",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020903",
    "time": "2020-07-03 04:46:55",
    "許可證字號": "衛署藥輸字第020903號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/12\/21",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "109\/05\/09",
    "發證日期": "84\/05\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202090308",
    "中文品名": "延效保衛胎注射液",
    "英文品名": "DEPO-PROVERA S.A.S. 150 MG\/ML",
    "適應症": "不能手術及復發性或轉性或轉移性之子宮內膜癌之輔助療法及舒減療法、停經後婦女之乳癌、攝護腺癌、避孕",
    "劑型": "271滅菌懸液注射劑",
    "包裝": "注射針筒",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MEDROXYPROGESTERONE ACETATE",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0011000  PFIZER MANUFACTURING BELGIUM NV",
            "製造廠廠址": "RIJKSWEG 12, 2870, PUURS, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "30066000005 以荷爾蒙、第２９３７節之其他產品或殺精蟲劑為基料之化學避孕製劑Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6832000710",
            "成分名稱": "MEDROXYPROGESTERONE ACETATE",
            "含量描述": "150",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Depo-Prover 衛署藥輸020903-103-02-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020903&Seq=010&Type=9"
        },
        {
            "title": "外盒標籤核定本20050413-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020903&Seq=001&Type=8"
        }
    ]
}